12 drug(s) with this reaction
32,300 total reports
Insomnia has been reported as an adverse reaction across 12 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 32,300 adverse event reports mention insomnia in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with insomnia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have insomnia listed in their FDA adverse event reports, sorted by report count:
In addition to insomnia, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
12 drug(s) manufactured by Abbvie Inc have insomnia listed in their FDA adverse event reports: LEVOTHYROXINE SODIUM, Humira, ADALIMUMAB, DIVALPROEX SODIUM, FENOFIBRATE, and others.
There are a combined 32,300 reports of insomnia across 12 Abbvie Inc drug(s) in the FDA adverse event database.